PT97544B - Processo para a separacao de eanantiomeros de cimaterol,(-)-(cimaterol e para a preparacao de composicoes farmaceuticas que os contem - Google Patents

Processo para a separacao de eanantiomeros de cimaterol,(-)-(cimaterol e para a preparacao de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT97544B
PT97544B PT97544A PT9754491A PT97544B PT 97544 B PT97544 B PT 97544B PT 97544 A PT97544 A PT 97544A PT 9754491 A PT9754491 A PT 9754491A PT 97544 B PT97544 B PT 97544B
Authority
PT
Portugal
Prior art keywords
cimaterol
acid
amino
ethanol
isopropylamino
Prior art date
Application number
PT97544A
Other languages
English (en)
Portuguese (pt)
Other versions
PT97544A (pt
Inventor
Wolfgang Resemann
Adolf Dury
Gunther Engelhardt
John Francis Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of PT97544A publication Critical patent/PT97544A/pt
Publication of PT97544B publication Critical patent/PT97544B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
PT97544A 1990-05-04 1991-05-02 Processo para a separacao de eanantiomeros de cimaterol,(-)-(cimaterol e para a preparacao de composicoes farmaceuticas que os contem PT97544B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (2)

Publication Number Publication Date
PT97544A PT97544A (pt) 1992-01-31
PT97544B true PT97544B (pt) 1998-08-31

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97544A PT97544B (pt) 1990-05-04 1991-05-02 Processo para a separacao de eanantiomeros de cimaterol,(-)-(cimaterol e para a preparacao de composicoes farmaceuticas que os contem

Country Status (27)

Country Link
US (4) US5248695A (enExample)
EP (2) EP0455155B1 (enExample)
JP (1) JP2944777B2 (enExample)
KR (1) KR0183024B1 (enExample)
AR (1) AR247728A1 (enExample)
AT (2) ATE124932T1 (enExample)
AU (1) AU645313B2 (enExample)
BG (1) BG60743B1 (enExample)
CA (1) CA2041818C (enExample)
CZ (1) CZ286389B6 (enExample)
DE (3) DE4014252A1 (enExample)
DK (2) DK0455155T3 (enExample)
ES (2) ES2109412T3 (enExample)
FI (1) FI109600B (enExample)
GR (2) GR3017064T3 (enExample)
HU (1) HU214335B (enExample)
ID (1) ID966B (enExample)
IE (2) IE69017B1 (enExample)
IL (1) IL98030A (enExample)
NO (1) NO174803B (enExample)
NZ (1) NZ238032A (enExample)
PT (1) PT97544B (enExample)
RU (1) RU2002737C1 (enExample)
SG (1) SG45439A1 (enExample)
SK (1) SK279258B6 (enExample)
TW (1) TW197415B (enExample)
ZA (1) ZA913337B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP0979081A4 (en) 1997-04-30 2003-05-02 Bridge Pharma Inc COMPOSITION AND METHODS USING EUTOMER
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
WO2004103057A2 (en) * 2003-05-15 2004-12-02 The University Of Georgia Research Foundation, Inc. Compositions and methods for inducing adipose tissue cell death
DK1663197T3 (da) * 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
WO2006108424A2 (en) * 2005-04-13 2006-10-19 Astion Pharma A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
MY176727A (en) 2012-12-03 2020-08-20 Pfizer Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (enExample) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
IE80651B1 (en) 1998-11-04
CA2041818C (en) 2003-02-11
JPH04225944A (ja) 1992-08-14
EP0455155A1 (de) 1991-11-06
CS129291A3 (en) 1991-11-12
NO174803C (enExample) 1994-07-13
NO911746L (no) 1991-11-05
NO174803B (no) 1994-04-05
GR3017064T3 (en) 1995-11-30
IE911507A1 (en) 1991-11-06
KR910019966A (ko) 1991-12-19
JP2944777B2 (ja) 1999-09-06
US5248695A (en) 1993-09-28
US5648386A (en) 1997-07-15
AR247728A1 (es) 1995-03-31
HUT60999A (en) 1992-11-30
ZA913337B (en) 1993-01-27
DE4014252A1 (de) 1991-11-07
SK279258B6 (sk) 1998-08-05
FI912151L (fi) 1991-11-05
US5292753A (en) 1994-03-08
BG94342A (en) 1994-06-30
ES2075255T3 (es) 1995-10-01
DE59108853D1 (de) 1997-10-23
PT97544A (pt) 1992-01-31
CA2041818A1 (en) 1991-11-05
FI109600B (fi) 2002-09-13
BG60743B1 (bg) 1996-02-29
NO911746D0 (no) 1991-05-03
DK0455155T3 (da) 1995-11-13
TW197415B (enExample) 1993-01-01
US5395957A (en) 1995-03-07
SG45439A1 (en) 1998-01-16
FI912151A0 (fi) 1991-05-03
EP0455155B1 (de) 1995-07-12
DE59105957D1 (de) 1995-08-17
HU214335B (hu) 1998-03-02
HU911502D0 (en) 1991-11-28
EP0589488A1 (de) 1994-03-30
EP0589488B1 (de) 1997-09-17
KR0183024B1 (ko) 1999-05-15
RU2002737C1 (ru) 1993-11-15
NZ238032A (en) 1996-02-27
ID966B (id) 1996-09-30
CZ286389B6 (cs) 2000-03-15
IL98030A0 (en) 1992-06-21
AU7611191A (en) 1991-11-07
IL98030A (en) 1995-12-31
IE69017B1 (en) 1996-07-24
ES2109412T3 (es) 1998-01-16
ATE158277T1 (de) 1997-10-15
ATE124932T1 (de) 1995-07-15
DK0589488T3 (da) 1998-05-04
GR3025547T3 (en) 1998-03-31
AU645313B2 (en) 1994-01-13

Similar Documents

Publication Publication Date Title
CA2041818C (en) Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers
DE69101595T2 (de) Verfahren zum aufzüchten von fleisch produzierenden tieren zur erhöhung der entwicklung von magerem fleisch.
EP0400011B1 (de) Neue phenylethanolamine
DE2953334C1 (de) 3-(2,2,2-Trimethylhydrazinium)propionat,Verfahren zu dessen Herstellung und Futtermittel,welche dieses enthalten
HK38289A (en) Method for promoting growth and reducing fat in animals using phenylethanolamine derivatives
PL144053B1 (en) Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
DE2432799C2 (de) 7-substituierte 5-Methyl-isoflavone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Metabolica
DE2125245C3 (de) Isoflavone und Verfahren zu deren Herstellung
EP0103830A2 (de) Wachstumsfördernde Phenylethylamin-Derivate
US3097136A (en) Process for producing a depressant-like effect on the central nervous system
US4880834A (en) Method for administering ethanolamine derivatives to livestock
Boothby THE PARATHYROID GLANDS A REVIEW OP THE LITERATURE
PT98884B (pt) Processo para a preparacao de fenil-etanol-aminas e de composicoes farmaceuticas que as contem
EP0057900A1 (de) Neuer Futterzusatz zur Verbesserung des Wachstums
Roy TOXICITY AND METABOLISM OF BETA-AMINOPROPIONITRILE AND RELATED COMPOUNDS IN CHICKS, TURKEYS AND RATS.
KR20210141956A (ko) 동물사료 첨가제를 제조하기 위한 γ-4차 암모늄 부티레이트계 화합물의 용도
DE3636605A1 (de) Verfahren zur trennung der enantiomeren von 1-(4-amino-3,5-dichlorphenyl)-2-(tert.-butyl) -hydroxy-amino-ethanol sowie deren verwendung als leistungsfoerderer bei tieren
DD202240A5 (de) Tierfutterergaenzungsmittel

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910925

FG3A Patent granted, date of granting

Effective date: 19980518

NF3A Restitutio in integrum

Free format text: 19991223 RESTITUTIO IN INTEGRUM

MM3A Annulment or lapse

Effective date: 20041118